Table 2 Metabolites that were nominally different (nominal p < 0.05) between Screening and Year 3 in Fast Progressors (A) (n = 7, 3, respectively), Absent Progressors (B) (n = 13, 10 respectively), and both groups (C).

From: An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington’s disease

  1. *Indicate nominal significance: *0.01 < p < 0.05; **0.001 < p < 0.01 and ***p < 0.001. No asterisk indicates  trending (0.05 < p < 0.10). Color indicates relative change from Screening to Year 3 (Red = increase; Blue = decrease). Shorthand notation10 for the lipids are provided in Table S2.
Back to article page